@article{ref1,
title="Long-term puberty suppression for a nonbinary teenager",
journal="Pediatrics",
year="2020",
author="Pang, Ken C. and Notini, Lauren and McDougall, Rosalind and Gillam, Lynn and Savulescu, Julian and Wilkinson, Dominic and Clark, Beth A. and Olson-Kennedy, Johanna and Telfer, Michelle M. and Lantos, John D.",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="Many transgender and gender-diverse people have a gender identity that does not conform to the binary categories of male or female; they have a nonbinary gender. Some nonbinary individuals are most comfortable with an androgynous gender expression. For those who have not yet fully progressed through puberty, puberty suppression with gonadotrophin-releasing hormone agonists can support an androgynous appearance. Although such treatment is shown to ameliorate the gender dysphoria and serious mental health issues commonly seen in transgender and gender-diverse young people, long-term use of puberty-suppressing medications carries physical health risks and raises various ethical dilemmas. In this Ethics Rounds, we analyze a case that raised issues about prolonged pubertal suppression for a patient with a nonbinary gender.<br><br>Copyright © 2020 by the American Academy of Pediatrics.<p /> <p>Language: en</p>",
language="en",
issn="0031-4005",
doi="10.1542/peds.2019-1606",
url="http://dx.doi.org/10.1542/peds.2019-1606"
}